Erdal Belen

Early changes in left ventricular mass index after empagliflozin initiation in type 2 diabetes: a retrospective cohort study

Sodium-glucose cotransporter-2 inhibitors (SGLT2i) promote reverse cardiac remodeling; however, evidence regarding very early changes in left ventricular mass index (LVMI) in patients with type 2 diabetes without established cardiovascular disease remains limited. We evaluated 3-...